NasdaqGS - Delayed Quote • USD
Shockwave Medical, Inc. (SWAV)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 13 | 13 |
| Avg. Estimate | 0.98 | 1.2 | 4.85 | 6.18 |
| Low Estimate | 0.83 | 1.07 | 4.09 | 5.3 |
| High Estimate | 1.24 | 1.5 | 6.18 | 7.19 |
| Year Ago EPS | 1.03 | 0.76 | 3.85 | 4.85 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 13 | 13 |
| Avg. Estimate | 207.69M | 226.67M | 920.88M | 1.13B |
| Low Estimate | 205M | 223.73M | 917.4M | 1.08B |
| High Estimate | 210.1M | 230.06M | 925.03M | 1.17B |
| Year Ago Sales | 147.31M | 180.16M | 730.23M | 920.88M |
| Sales Growth (year/est) | 41.00% | 25.80% | 26.10% | 23.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.81 | 0.85 | 0.79 | 0.89 |
| EPS Actual | 1.03 | 0.76 | 0.92 | 1.16 |
| Difference | 0.22 | -0.09 | 0.13 | 0.27 |
| Surprise % | 27.20% | -10.60% | 16.50% | 30.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.98 | 1.2 | 4.85 | 6.18 |
| 7 Days Ago | 0.98 | 1.2 | 4.85 | 6.18 |
| 30 Days Ago | 0.98 | 1.2 | 4.85 | 6.18 |
| 60 Days Ago | 0.96 | 1.2 | 4.84 | 6.12 |
| 90 Days Ago | 0.92 | 1.09 | 4.44 | 5.88 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SWAV | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -4.90% | -- | -- | 6.50% |
| Next Qtr. | 57.90% | -- | -- | 12.00% |
| Current Year | 26.00% | -- | -- | 5.30% |
| Next Year | 27.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 25.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | CL King: Buy to Neutral | 4/8/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 4/8/2024 |
| Downgrade | Deutsche Bank: Buy to Hold | 4/8/2024 |
| Downgrade | Morgan Stanley: Overweight to Equal-Weight | 4/8/2024 |
| Downgrade | Canaccord Genuity: Buy to Hold | 4/5/2024 |
| Downgrade | Needham: Buy to Hold | 4/5/2024 |
Related Tickers
NARI Inari Medical, Inc.
38.42
+0.92%
TMDX TransMedics Group, Inc.
92.08
+3.17%
PODD Insulet Corporation
166.19
+1.23%
EW Edwards Lifesciences Corporation
86.43
-1.80%
INSP Inspire Medical Systems, Inc.
237.45
+2.79%
DXCM DexCom, Inc.
124.34
-9.91%
PRCT PROCEPT BioRobotics Corporation
51.83
-0.86%
BSX Boston Scientific Corporation
73.17
-0.12%
PEN Penumbra, Inc.
204.41
-0.53%
SYK Stryker Corporation
335.61
-0.46%